Skip to content

Post-operative ano-rectal pain management by Ayurvedic drug to observe changes in inflammatory biomarkers.

Efficacy of Eranda (Ricinus Communis) leaf extract on inflammatory Biomarkers (IL 6 TNF alpha) in post operative pain of AnoRectal cases operated under LA A Randomized Controlled Clinical Trial - Nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073065
Enrollment
30
Registered
2024-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G891- Acute pain, not elsewhere classified

Interventions

None listed

Sponsors

KLE Society
Lead Sponsor
Dr Tarun Pawar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have undergone anorectal surgical intervention, under LA

Exclusion criteria

Exclusion criteria: 1} Patients suffering from systemic diseases such as cardiac diseases, renal failure etc. 2} Patients suffering from septic conditions.

Design outcomes

Primary

MeasureTime frame
Eranda Leaf extract is effective in the post-operative pain of anorectal cases operated under LATimepoint: Base line, 30min, 1hr, 3hr, 8hr, 16hr, 24hr, 32hr, 40hr, 48hr

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Santosh Y M

KLE Society

drmysantosh@gmail.com9964498818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026